D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims

Annals of the New York Academy of Sciences

Volumn 877, Issue , 1999, Pages 507-522

  Mash, Deborah C ^a   Staley, Julie K ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; CYCLOPHILIN; DOPAMINE 3 RECEPTOR; KAPPA OPIATE RECEPTOR; MARKER; MESSENGER RNA; OPIATE; 7 HYDROXY 2 N,N DIPROPYLAMINOTETRALIN; 7-HYDROXY-2-N,N-DIPROPYLAMINOTETRALIN; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DRD3 PROTEIN, HUMAN; OXYMORPHONE; PEPTIDYLPROLYL ISOMERASE; RADIOACTIVE IODINE; TETRALIN DERIVATIVE; TRITIUM;

AMYGDALOID NUCLEUS; AUTORADIOGRAPHY; BEHAVIOR; BRAIN LEVEL; CAUDATE NUCLEUS; COCAINE DEPENDENCE; CONFERENCE PAPER; CONTROLLED STUDY; DELIRIUM; DOPAMINE UPTAKE; DRUG OVERDOSE; EMOTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIGAND BINDING; MESOLIMBIC DOPAMINERGIC SYSTEM; MOTIVATION; NUCLEUS ACCUMBENS; PUTAMEN; THALAMUS VENTRAL NUCLEUS; ARTICLE; BRAIN; CAUSE OF DEATH; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; INTOXICATION; LIMBIC SYSTEM; METABOLISM; PATHOLOGY;

AUTORADIOGRAPHY; BRAIN; CAUSE OF DEATH; COCAINE; DOPAMINE AGONISTS; GENE EXPRESSION REGULATION; HUMANS; IODINE RADIOISOTOPES; LIMBIC SYSTEM; NUCLEUS ACCUMBENS; OVERDOSE; OXYMORPHONE; PEPTIDYLPROLYL ISOMERASE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, OPIOID, KAPPA; TETRAHYDRONAPHTHALENES; TRANSCRIPTION, GENETIC; TRITIUM;

EID: 0032588736     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09286.x     Document Type: Conference Paper

References (57)

1. 1. Nestler, E.J., B.T. Hope & K.L. Widnell, 1993, Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11: 995-1006.
2. 2. Ritz, M.C., S.R. Lamb, S.R. Goldberg & M.J. Kuhar. 1987. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223.
3. 3. Reith, M.E.A., H.K. Kramer, H. Sershen & A. Lajtha. 1989. Cocaine competitively inhibits catecholamine uptake into brain synaptic vesicles. Res. Commun. Substances Abuse 10: 205-208.
4. 4. Kuhar, M.J., M.C. Ritz & J.W. Boja. 1991. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14: 299-302.
5. 3 dopamine receptors. Science 260: 1814-1815.
6. 6. Caine, S.B. & G.F. Koob. 1995. Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav. Pharmacol. 6: 333-347.
7. 7. Bouthenet, M.L., E. Souil, M.P. Martres, P. Sokoloff, B. Giros & J.C. Schwartz. 1991. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA, Brain Res. 564: 203-219.
8. 8. Mengod, G., M.T. Villaro, G.B. Landwehrmeyer et al. 1992. Visualization of dopamine D1, D2, and D3 receptor mRNAs in human and rat brain, Neurochem. Int, Suppl. 20: 33S-43S.
9. 3 H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. USA 89; 8155-8159.
10. 10. Landwehrmeyer, B., G. Mengod & J.M. Palacios. 1993b. Dopamine D3 receptor mRNA and hinding sites in human brain. Mol. Brain Res. 18: 187-192.
11. 11. Murray, A.M., H.L. Ryoo, E. Gurevich & J.N. Joyce. 1994. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc. Natl. Acad. Sci. USA 91: 11271-11275.
12. 12. Roberts, D.C.S. & R. Ranaldi. 1995. Effect of dopaminergic drugs on cocaine reinforcement, Clin. Neuropharmacol. 18: SR4-S95.
13. 13. NADER, M.A. & R.H. MACH. 1996. Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure. Psychopharmacology. In press.
14. 14. DiChiara, G. & A. Imperato. 1988. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244: 1067-1080.
15. 15. Spanagel, R., A. Herz & T. Shippenberg. 1990. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem. 55: 1734-1740.
16. 16. Spanagel, R., A. Herz & T.S. Shippenberg. 1992. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA 89: 2046-2050.
17. 17. Shippenberg, T.S., A, LeFevour & C. Heidhreder. 1996. Kappa opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. J. Pharmacol. Exp. Ther. 276: 545-554.
18. 18. Shippenberg, T.S., A. Herz, R. Spanagel, R. Bals-Kubik & C. Stein. 1992. Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates. Ann. N.Y. Acad. Sci. 654: 347-356.
19. 19. Glick, S.D., I.M. Maisonneuve, J. Raucci & S. Archer. 1995. Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res. 681:147-152.
20. 20. Suzuki, T., Y, Shiozaki, Y. Masukawa, M. Misawa & H. Nagase. 1992. The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference. Jpn. J. Pharmacol. 58: 435-442.
21. 21. Heidbreder, C.A., S.R. Goldberg & T.S. Shippenberg, 1993. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res. 616: 335-338.
22. 22. Heidbreder, C.A., D. Babovic-Vuksanovic, M. Shoaib & T.S. Shippenberg. 1995. Development of behavioral sensitization to cocaine: Influence of kappa opioid receptor agonists. J. Pharmacol. Exp. Ther. 275: 150-163.
23. 23. Shippenberg, T.S. & C.H. Heidbreder. 1994, Kappa opioid receptor agonists prevent sensitization to the rewarding effects of cocaine. NIDA Res. Monograph 153: 456.
24. 24. Mello, N.K., J.B. Kamien, S.E. Lukas, J.H. Mendelson, Drieze J.M. & J.W. Sholar. 1993. Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys. J. Pharmacol. Exp. Ther. 264: 530-541.
25. 25. Comer, S.D., S.T. Lac, L.K. Curtis & M.E. Carroll. 1993. Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats. J. Pharmacol. Exp. Ther. 267: 1470-1477.
26. 26. Wetli, C.V. & D.A. Fishbain. 1985. Cocaine-induced psychosis and sudden death in recreational cocaine users. J. Forensic Sci. 30: 873-880.
27. 27. Wetli, C.V., D.C. Mash & S.B. Karch. 1996. Cocaine-associated agitated delirium and the neuroleptic malignant syndrome. Am. J. Emerg. Med. 14: 425-428.
28. 28. Ruttenber, A.J., J. Lawler-Heavner, M. Yin, C.V. Wetli, W.L. Hearn & D.C. Mash. 1997. Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity. J. Anal. Toxicol. 42: 25-31.
29. 29. Hernandez, A., W. Andollo & W.L. Hearn. 1994. Analysis of cocaine and metabolites in brain using solid phase extraction and full-scanning and GC/ion trap mass spectrometry. Forensic Sci. Int. 65: 149-156.
30. 3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J. Neurosci. 16: 6100-6106.
31. 31. Staley, J.K. R.B. Rothman, K.C. Rice, J. Partilla & D.C. Mash. 1997. Kappa2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims. J. Neurosci. 17 (21): 8225-33.
32. 32. Segal, D.M., C.T. Moreas & D.C. Mash. 1997. Upregulation of D3 dopamine receptor mRNA in the nucleus accumbens from human cocaine overdose victims. Mol. Brain Res. 45(2): 335-339.
33. 3 receptor: Chinese hamsters or Chinese whispers. Trends Pharmacol. Sci. 15: 46-47.
34. 3 receptors in rat olfactory tubercle. J. Pharmacol. Exp. Ther. 268: 935-942.
35. 35. Self, D.W., W.J. Barnhart, D.A, Lehman & E.J. Nestler. 1996. Opposite modulation of cocaine-seeking behavior by D1-like and D2-like dopamine receptor agonists. Science 271: 1586-1589.
36. 3) as a target for neuroleptics. Nature 347: 146-151.
37. 37. Koob, G.F. & F.E. Bloom. 1988. Molecular and cellular mechanisms of drug dependence. Science 242: 715-723.
38. 38. Schmaus, C., V. Haroutunian, K.L. Davis & M. Davidson. 1993. Selective loss of dopamine D-3 type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc. Natl. Acad. Sci. 90: 8942-8946.
39. 39. Unterwald, E.M., J.M. Rubenfeld & M.J. Kreek. 1994. Repeated cocaine administration upregulates kappa and mu but not delta opioid receptors. Neuroreport 5: 1613-1616.
40. 40. Hammer, R.P. 1989. Cocaine alters opiate receptor binding in critical brain reward regions. Synapse 3: 55-60.
41. 41. Hurd, Y.L. & M. Herkenham. 1993. Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13: 357-369.
42. 42. Werling, L.L., A. Frattali, P.S. Portoghese, A.E. Takemori & B.M. Cox. 1988. Kappa-receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. . Pharmacol. Exp. Ther. 246: 282-286.
43. 1 receptor mRNA distribution in the rat CNS: comparison to κ receptor binding and prodynorphin mRNA. Mol. Cell. Neurosci. 5: 124-144.
44. 44. Hurd, Y.L., E.E. Brown, J.M. Finlay, H.C. Fibiger & C.R. Gerfen. 1992. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol. Brain Res. 13: 165-170.
45. 45. Sivam, S.P. 1989. Cocaine selectively increases striatonigral dynorphin levels by dopaminergic mechanism. J. Pharmacol. Exp. Therap. 250: 818-824.
46. 46. Smiley, P.L., M. Johnson, L. Bush, J.W. Gibb & G.R. Hanson. 1990. Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharmacol. Exp. Ther. 253: 938-943.
47. 47. Spangler, R., E.M. Unterwald & M.J. Kreek. 1993. "Binge" cocaine administration induced a sustained increase of prodynorphin mRNA in rat caudate-putamen. Mol. Brain Res. 19: 323-327.
48. 1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediatcd behavioral responses. Cell 79: 729-742.
49. 49. Steiner, H. & C.R. Gerfen. 1996. Dynorphin regulates D1 dopaminc receptor-mediated responses in the striatum: relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate early gene induction. J. Comp. Neurol. 376: 530-541.
50. 50. Broadbent, J., T.M. Gaspard & S.I. Dworkin. 1995. Assessment of the discriminative stimulus effects of cocaine in the rat: lack of interaction with opioids. Pharmacol. Biochem. Behav. 51: 379-385.
51. 51. Ukai, M., E. Mori & T. Kameyama. 1995. Effects of centrally administered neuropeptides on discriminative stimulus properties of cocaine in the rat. Pharmacol. Biochem. Bchav. 51: 705-708.
52. 52. Spealman, R.D. & J. Bergman. 1992. Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J. Pharmacol. Exp. Ther. 261: 607-615.
53. 53. Kumor, K.M., C.A. Haertzen, R.E. Johnson, T. Kocher & D. Jasinski. 1986. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo. J. Pharmacol. Exp. Ther. 238: 960-968.
54. 54. Pfeiffer, A., V. Brandt & A. Herz. 1986. Psychotomimesis mediated by kappa opiate receptors. Science 233: 774-776.
55. 55. Ben-Ari, Y. 1981. The Amygdaloid Complex. Elsevier North-Holland Biomedical Press. Amsterdam.
56. 56. Kling, A, H.D. Steklis & S. Deutsch. 1979. Radiotelemetered activity from the amygdala during social interactions in the monkey, Exp. Neurol. 66: 88-96.
57. 57. Andy, O.J. & M.F. Jurko. 1972. Hyperresponsive syndrome. In Psychosurgery. E. Hitchcock, L. Laitinen & K. Vaernet, Eds.: 117-126. Thomas. Springfield, IL.